Lung Cancer — 5-Minute Journal Club with Dr Natalie Vokes: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays

About this episode

Dr. Natalie Vokes discusses the role of circulating tumor DNA assays in lung cancer management.

Dr Natalie Vokes from The University of Texas MD Anderson Cancer Center in Houston discusses recent developments with circulating tumor DNA assays in the management of lung cancer. CME information and select publications here .

People in this episode

Host: Dr. Neil Love

Guest: Dr Natalie Vokes

Topics covered

• lung cancer
• circulating tumor DNA
• assays
• cancer management
• recent developments

Keywords

• lung cancer
• circulating tumor DNA
• assays
• cancer management
• CME

Mentioned in this episode

Organizations: The University of Texas MD Anderson Cancer Center, Oncology Today

More episodes of Oncology Today with Dr Neil Love

• Localized Renal Cell Carcinoma — Proceedings from a Session Held in Conjunction with the 2026 American Urological Association Annual Meeting · June 12, 2026 · 1h 29m
• HR-Positive Metastatic Breast Cancer — A Discussion and Debate on First- and Second-Line Therapy · June 11, 2026 · 58 min
• Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances · June 8, 2026 · 59 min
• Genitourinary Cancers — 5-Minute Journal Club Issue 2 with Professor Thomas Powles: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays · June 5, 2026 · 23 min
• Antibody-Drug Conjugates in Gynecologic Cancers — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women's Cancer · June 3, 2026 · 1h 31m
• Desmoid Tumors — Microlearning Activity 3 with Prof Bernd Kasper · June 2, 2026 · 23 min